Abstract
Background
Chronic obstructive pulmonary disease (COPD) is a leading cause of disability and death worldwide, imposing a substantial socioeconomic burden on societies and patients due to the long-term management required.
Objective
To assess the economic burden of COPD in Greece and its potential determinants.
Methods
A population-based, random-digit dialled, telephone nationwide survey was conducted to recruit patients with COPD in Greece (N = 351). A structured questionnaire was used to collect data. The total annual cost per patient from a societal perspective was calculated.
Results
The mean (95% CI) annual total cost per patient for the management of COPD from a societal perspective was €2150 (€1879–€2443). The total annual cost was mainly driven by the medication cost (36.1%), followed by the cost of hospitalizations (26.7%) and long-term oxygen therapy (13.8%). Multiple generalized linear model revealed that age, COPD Assessment Test (CAT) score and exacerbations were independently associated with the total annual cost.
Conclusion
Investment in interventions aiming at delaying progression of disease, preventing acute exacerbations, and managing chronic symptoms are required to reduce the overall economic burden of COPD in Greece.
Similar content being viewed by others
References
Soriano JB, Rodriguez-Roisin R. Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation. Proc Am Thorac Soc. 2011;8(4):363–7.
Shavelle RM, Paculdo DR, Kush SJ, Mannino DM, Strauss DJ. Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study. Int J Chron Obstruct Pulmon Dis. 2009;4:137–48.
Wouters EF. Economic analysis of the confronting COPD survey: an overview of results. Respir Med. 2003;97 Suppl C:S3–14.
Fletcher MJ, Upton J, Taylor-Fishwick J, Buist SA, Jenkins C, Hutton J, et al. COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population. BMC Public Health. 2011;11:612.
Detournay B, Pribil C, Fournier M, Housset B, Huchon G, Huas D, et al. The SCOPE study: health-care consumption related to patients with chronic obstructive pulmonary disease in France. Value Health. 2004;7(2):168–74.
Foster TS, Miller JD, Marton JP, Caloyeras JP, Russell MW, Menzin J. Assessment of the economic burden of COPD in the US: a review and synthesis of the literature. COPD. 2006;3(4):211–8.
Menzin J, Boulanger L, Marton J, Guadagno L, Dastani H, Dirani R, et al. The economic burden of chronic obstructive pulmonary disease (COPD) in a US Medicare population. Respir Med. 2008;102(9):1248–56.
Polatli M, Ben Kheder A, Wali S, Javed A, Khattab A, Mahboub B, et al. Chronic obstructive pulmonary disease and associated healthcare resource consumption in the Middle East and North Africa: the BREATHE study. Respir Med. 2012;106(Suppl 2):S75–85.
Kourlaba G, Hillas G, Vassilakopoulos T, Maniadakis N. The disease burden of chronic obstructive pulmonary disease in Greece. Int J Chron Obstruct Pulmon Dis. 2016 (in press).
Geitona M, Hatzikou M, Steiropoulos P, Alexopoulos EC, Bouros D. The cost of COPD exacerbations: a university hospital–based study in Greece. Respir Med. 2011;105(3):402–9.
Souliotis K, Kousoulakou H, Hillas G, Tzanakis N, Toumbis M, Vassilakopoulos T. The direct and indirect costs of managing chronic obstructive pulmonary disease in Greece. Int J Chron Obstruct Pulmon Dis. 2017;12:1395–400.
Stafyla E, Geitona M, Kerenidi T, Economou A, Daniil Z, Gourgoulianis KI. The annual direct costs of stable COPD in Greece. Int J Chron Obstruct Pulmon Dis. 2018;13:309–15.
Landis SH, Muellerova H, Mannino DM, Menezes AM, Han MK, van der Molen T, et al. Continuing to confront COPD international patient survey: methods, COPD prevalence, and disease burden in 2012–2013. Int J Chron Obstruct Pulmon Dis. 2014;9:597–611.
Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–54.
Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38(1):29–35.
Uzaslan E, Mahboub B, Beji M, Nejjari C, Tageldin MA, Khan JA, et al. The burden of chronic obstructive pulmonary disease in the Middle East and North Africa: results of the BREATHE study. Respir Med. 2012;106(Suppl 2):S45–59.
Greek Ministry of Health M. Drug price bulletin. 2015.
International Monetary Fund. World Economic Outlook Database. 2013. http://www.imf.org/external/pubs/ft/weo/2012/02/weodata/index.aspx.
WHO. Policy dialogue to reduce out-of-pocket payments for health in Greece. 2018. http://www.euro.who.int/en/countries/greece/news/news/2018/5/policy-dialogue-to-reduce-out-of-pocket-payments-for-health-in-greece.
Jonsson B. Ten arguments for a societal perspective in the economic evaluation of medical innovations. Eur J Health Econ. 2009;10(4):357–9.
Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med. 2000;19(23):3219–36.
Moran JL, Solomon PJ, Peisach AR, Martin J. New models for old questions: generalized linear models for cost prediction. J Eval Clin Pract. 2007;13(3):381–9.
Kamusheva M, Dimitrova M, van Boven JF, Postma MJ, van der Molen T, Kocks JW, et al. Clinical characteristics, treatment patterns, and socio-economic burden of COPD in Bulgaria. J Med Econ. 2017;20(5):503–9.
de Miguel Diez J, Carrasco Garrido P, Garcia Carballo M, Gil de Miguel A, Rejas Gutierrez J, Bellon Cano JM, et al. Determinants and predictors of the cost of COPD in primary care: a Spanish perspective. Int J Chron Obstruct Pulmon Dis. 2008;3(4):701–12.
Dal Negro RW, Tognella S, Tosatto R, Dionisi M, Turco P, Donner CF. Costs of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO study (social impact of respiratory integrated outcomes). Respir Med. 2008;102(1):92–101.
Kim J, Lee TJ, Kim S, Lee E. The economic burden of chronic obstructive pulmonary disease from 2004 to 2013. J Med Econ. 2015;2015:1–8.
Khakban A, Sin DD, FitzGerald JM, Ng R, Zafari Z, McManus B, et al. Ten-year trends in direct costs of COPD: a population-based study. Chest. 2015;148(3):640–6.
Migdalis I, Rombopoulos G, Hatzikou M, Manes C, Kypraios N, Tentolouris N. The cost of managing Type 2 diabetes mellitus in Greece: a retrospective analysis of 10-year patient level data “The HERCULES Study”. Int J Endocrinol. 2015;2015:520759.
Maniadakis N, Kourlaba G, Cokkinos DV, Angeli A, Kyriopoulos J. The economic burden of atherothrombosis in Greece: results from the THESIS study. Eur J Health Econ. 2013;14(4):655–65.
Holbrook AL, Green MC, Krosnick JA. Telephone versus face-to-face interviewing of national probability samples with long questionnaires: comparisons of respondent satisficing and social desirability response bias. Public Opinion Q. 2003;67:79–125.
Author information
Authors and Affiliations
Contributions
GK designed the study, conducted the analyses, interpreted the results, and wrote the manuscript. NM, GH, and TV contributed to questionnaire development, results interpretation, and manuscript writing.
Corresponding author
Ethics declarations
Data availability statement
The dataset along with the software code will be provided upon request.
Conflict of interest
The authors Georgia Kourlaba, Georgios Hillas, Theodoros Vassilakopoulos, and Nikos Maniadakis declare that they have no conflicts of interest.
Funding
This study was funded by the Hellenic Thoracic Society.
Ethical approval
According to the Greek legislation (Law 2328/1995, Presidential Decree 310/1996, Law 3603/2007, Law 2472/1997, Law 3471/2006) there is no need for ethical approval for telephone surveys such the one presented here (Association of Opinion Polls and Survey Organisations—http://www.sedea.gr).
Informed consent
Verbal informed consent was obtained from all individual participants included in the study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kourlaba, G., Hillas, G., Vassilakopoulos, T. et al. The Economic Burden of Chronic Obstructive Pulmonary Disease in Greece. Appl Health Econ Health Policy 17, 111–121 (2019). https://doi.org/10.1007/s40258-018-0431-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40258-018-0431-5